Market Closed -
OTC Markets
15:46:15 2024-05-28 EDT
|
5-day change
|
1st Jan Change
|
2.946
USD
|
-6.77%
|
|
-11.66%
|
-60.46%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
114,126
|
353,422
|
318,544
|
223,341
|
113,607
|
45,273
|
-
|
-
|
Enterprise Value (EV)
1 |
109,822
|
348,931
|
312,303
|
219,728
|
108,159
|
38,023
|
37,083
|
34,347
|
P/E ratio
|
116
x
|
216
x
|
97.9
x
|
52.3
x
|
34.9
x
|
12.2
x
|
9.55
x
|
8.51
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
28.6
x
|
63
x
|
31
x
|
14.6
x
|
6.67
x
|
2.5
x
|
2.1
x
|
1.87
x
|
EV / Revenue
|
27.6
x
|
62.2
x
|
30.4
x
|
14.4
x
|
6.35
x
|
2.1
x
|
1.72
x
|
1.42
x
|
EV / EBITDA
|
65.7
x
|
142
x
|
68
x
|
32
x
|
15.5
x
|
5.94
x
|
4.8
x
|
4.03
x
|
EV / FCF
|
-54.8
x
|
-83.5
x
|
-101
x
|
-673
x
|
-
|
97.2
x
|
14.2
x
|
16.8
x
|
FCF Yield
|
-1.82%
|
-1.2%
|
-0.99%
|
-0.15%
|
-
|
1.03%
|
7.02%
|
5.96%
|
Price to Book
|
8.93
x
|
17.2
x
|
10.3
x
|
6.37
x
|
2.9
x
|
1.02
x
|
0.9
x
|
0.82
x
|
Nbr of stocks (in thousands)
|
3,883,578
|
4,084,763
|
4,224,123
|
4,225,262
|
4,222,732
|
4,157,156
|
-
|
-
|
Reference price
2 |
29.39
|
86.52
|
75.41
|
52.86
|
26.90
|
10.89
|
10.89
|
10.89
|
Announcement Date
|
20-03-26
|
21-03-23
|
22-03-22
|
23-03-22
|
24-03-26
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
3,984
|
5,612
|
10,290
|
15,269
|
17,034
|
18,137
|
21,589
|
24,249
|
EBITDA
1 |
1,671
|
2,464
|
4,590
|
6,857
|
6,993
|
6,404
|
7,723
|
8,527
|
EBIT
1 |
1,156
|
2,008
|
3,327
|
4,609
|
4,253
|
4,818
|
5,984
|
6,856
|
Operating Margin
|
29.02%
|
35.79%
|
32.33%
|
30.18%
|
24.97%
|
26.56%
|
27.72%
|
28.27%
|
Earnings before Tax (EBT)
1 |
1,127
|
1,966
|
3,993
|
5,358
|
4,174
|
4,667
|
5,880
|
6,623
|
Net income
1 |
1,010
|
1,689
|
3,388
|
4,420
|
3,400
|
3,852
|
4,867
|
5,478
|
Net margin
|
25.36%
|
30.09%
|
32.93%
|
28.95%
|
19.96%
|
21.24%
|
22.54%
|
22.59%
|
EPS
2 |
0.2533
|
0.4000
|
0.7700
|
1.010
|
0.7700
|
0.8941
|
1.141
|
1.279
|
Free Cash Flow
1 |
-2,003
|
-4,178
|
-3,106
|
-326.7
|
-
|
391.4
|
2,604
|
2,046
|
FCF margin
|
-50.27%
|
-74.44%
|
-30.19%
|
-2.14%
|
-
|
2.16%
|
12.06%
|
8.44%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
6.11%
|
33.72%
|
23.99%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
10.16%
|
53.51%
|
37.35%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-03-26
|
21-03-23
|
22-03-22
|
23-03-22
|
24-03-26
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
1,944
|
3,668
|
4,407
|
5,883
|
7,206
|
8,062
|
8,492
|
8,542
|
7,852
|
9,835
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
1,773
|
1,553
|
2,484
|
2,054
|
2,434
|
1,819
|
2,033
|
2,445
|
Operating Margin
|
-
|
-
|
40.24%
|
26.4%
|
34.47%
|
25.47%
|
28.66%
|
21.29%
|
25.9%
|
24.86%
|
Earnings before Tax (EBT)
|
-
|
1,261
|
-
|
-
|
-
|
2,428
|
2,529
|
1,645
|
-
|
-
|
Net income
|
-
|
952.8
|
-
|
1,546
|
-
|
1,885
|
2,267
|
1,133
|
-
|
-
|
Net margin
|
-
|
25.97%
|
-
|
26.28%
|
-
|
23.38%
|
26.69%
|
13.26%
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
0.5200
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-09-21
|
21-03-23
|
21-08-23
|
22-03-22
|
22-08-17
|
23-03-22
|
23-08-23
|
24-03-26
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
4,304
|
4,491
|
6,241
|
3,612
|
5,448
|
7,250
|
8,189
|
10,926
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-2,003
|
-4,178
|
-3,106
|
-327
|
-
|
391
|
2,604
|
2,046
|
ROE (net income / shareholders' equity)
|
11.6%
|
10.1%
|
12.8%
|
13.1%
|
9.02%
|
8.98%
|
10.1%
|
10.2%
|
ROA (Net income/ Total Assets)
|
8.93%
|
7.25%
|
9.28%
|
9.45%
|
6.41%
|
6.8%
|
7.86%
|
8.07%
|
Assets
1 |
11,317
|
23,283
|
36,498
|
46,798
|
53,070
|
56,649
|
61,944
|
67,864
|
Book Value Per Share
2 |
3.290
|
5.030
|
7.300
|
8.290
|
9.270
|
10.70
|
12.10
|
13.30
|
Cash Flow per Share
2 |
0.3000
|
0.4400
|
0.7700
|
1.270
|
-
|
1.580
|
1.760
|
1.830
|
Capex
1 |
3,211
|
6,025
|
6,508
|
5,868
|
-
|
5,229
|
4,555
|
3,936
|
Capex / Sales
|
80.59%
|
107.35%
|
63.24%
|
38.43%
|
-
|
28.83%
|
21.1%
|
16.23%
|
Announcement Date
|
20-03-26
|
21-03-23
|
22-03-22
|
23-03-22
|
24-03-26
|
-
|
-
|
-
|
Last Close Price
10.89
CNY Average target price
24.91
CNY Spread / Average Target +128.74% Consensus |
1st Jan change
|
Capi.
|
---|
| +9.83% | 118B | | +10.80% | 106B | | -10.84% | 23.4B | | -1.69% | 22.1B | | -10.23% | 18.34B | | -41.92% | 16.59B | | -15.11% | 15.97B | | +6.62% | 14.03B | | +17.53% | 11.67B |
Bio Therapeutic Drugs
|